|
Market Closed -
Nasdaq
16:30:00 2026-11-06 EST
|
5-day change | 1st Jan Change | ||
| 0.6574 USD | -3.32% |
|
-7.66% | -42.33% |
| 10-26 | Top Premarket Gainers | MT |
| 10-12 | Iridex Says Glaucoma Therapy Lowers Eye Pressure, Reduces Medication Use | MT |
| Market Cap | 11.55M 10.36M 9.47M 8.64M 16.28M 1.09B 16.79M 114M 45.49M 579M 43.34M 42.41M 1.83B | P/E 2026 * |
-5.48x | P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 11.55M 10.36M 9.47M 8.64M 16.28M 1.09B 16.79M 114M 45.49M 579M 43.34M 42.41M 1.83B | EV / Sales 2026 * |
0.22x | EV / Sales 2027 * | 0.21x |
| Free-Float |
60.42% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| IRIX | Delayed | |
CBOE
| IRIX | Real-time |
Last Transcript: IRIDEX Corporation
| 1 day | -3.32% | ||
| 1 week | -7.66% | ||
| Current month | -7.66% | ||
| 1 month | -25.15% | ||
| 3 months | -20.84% | ||
| 6 months | -36.17% | ||
| Current year | -42.33% |
| 1 week | 0.66 |  | 0.78 |
| 1 month | 0.66 | | 0.98 |
| Current year | 0.61 | | 1.65 |
| 1 year | 0.61 | | 1.65 |
| 3 years | 0.61 | | 3.65 |
| 5 years | 0.61 | | 9.2 |
| 10 years | 0.61 | | 16.39 |
| Manager | Title | Age | Since |
|---|---|---|---|
Patrick Mercer
CEO | Chief Executive Officer | 54 | 2024-09-30 |
Romeo Dizon
DFI | Director of Finance/CFO | 68 | 2018-12-17 |
Philip Taylor
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Scott Shuda
CHM | Chairman | 60 | 2020-06-23 |
Patrick Mercer
BRD | Director/Board Member | 54 | 2018-08-31 |
Beverly A. Huss
BRD | Director/Board Member | 66 | 2022-03-16 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/1/26 | Tax | Chief Executive Officer | -23,917 | 0.1362% | ||
| 9/16/26 | Buy | Chief Financial Officer | 7,900 | 0.0450% | ||
| 9/14/26 | Buy | Chief Financial Officer | 2,354 | 0.0134% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.32% | -7.66% | -37.69% | -70.91% | 11.55M | |
| +2.63% | -0.32% | +21.37% | +51.28% | 257B | |
| +1.73% | -0.85% | +9.67% | +16.14% | 162B | |
| -3.36% | +4.81% | -19.14% | +62.47% | 157B | |
| -4.23% | +1.83% | -57.26% | -18.06% | 61.96B | |
| +1.31% | +11.01% | +22.48% | +53.52% | 58.73B | |
| -0.76% | +4.13% | +3.16% | -6.90% | 55.42B | |
| +1.73% | -0.06% | +19.09% | +58.10% | 49.27B | |
| -2.05% | -2.95% | +3.01% | +56.47% | 49.18B | |
| +1.00% | -1.11% | +23.11% | +75.55% | 44.96B | |
| Average | -0.53% | +0.46% | -1.22% | +27.77% | 89.59B | |
| Weighted average by Cap. | +0.26% | +1.20% | +4.62% | +40.52% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 52.52M 47.11M 43.05M 39.3M 74.04M 4.94B 76.38M 519M 207M 2.63B 197M 193M 8.32B | 55.98M 50.21M 45.88M 41.88M 78.91M 5.26B 81.4M 553M 221M 2.81B 210M 206M 8.86B |
| Net income | -2.09M -1.87M -1.71M -1.56M -2.94M -196M -3.03M -20.61M -8.22M -105M -7.83M -7.66M -330M | 1K 896.9 819.69 748.25 1.41K 94K 1.45K 9.88K 3.94K 50.16K 3.75K 3.67K 158K |
| Net Debt | - | - |
Employees
93
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-06 | US$0.6574 | -3.32% | 22,910 |
| 26-11-05 | US$0.6800 | -4.91% | 45,218 |
| 26-11-04 | US$0.7151 | +2.74% | 35,196 |
| 26-11-03 | US$0.6960 | -3.53% | 40,242 |
| 26-11-02 | US$0.7215 | +1.34% | 19,121 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.6574USD
Average target price
2.750USD
Spread / Average Target
+318.31%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IRIX Stock
Select your edition
All financial news and data tailored to specific country editions
